Cardiac Structural or Functional Changes Associated with CHA2DS2-VASc Scores in Nonvalvular Atrial Fibrillation: A Cross-Sectional Study Using Echocardiography
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
BACKGROUND: CHA2DS2-VASc is the most widely accepted scoring system for atrialfibrillation (AF) to assess stroke risk, although little has been revealed regarding theaccompanying cardiac functional/structural changes. This echocardiography study wasundertaken to understand the changes related to CHA2DS2-VASc scores. METHODS: A total of 4,795 nonvalvular AF patients were enrolled for the cohort, from which591 were excluded as they did not meet the inclusion criteria. Based on the CHA2DS2-VAScscores, the remaining 4,204 patients included in the study were divided into 4 groups: 0 to 1(n = 991); 2 to 3 (n = 1,642); 4 to 6 (n = 1,407); 7 to 9 (n = 164). RESULTS: Increase in the left ventricular mass index and prevalence of left ventricularhypertrophy (LVH) were observed with elevating CHA2DS2-VASc scores (p < 0.05 for all). Diastolic parameters such as left atrial volume index (LAVI) and the ratio of early diastolic mitralinflow velocity to early diastolic velocity of the mitral annulus (E/E′) also increased significantlyin the higher CHA2DS2-VASc score groups (p < 0.001 for all), although two-way ANOVA analysisshowed that such incremental diastolic impairment was independent of hypertension. LVH(hazard ratio [HR], 3.609; confidence interval [CI], 2.426–5.369; p < 0.001) and E/E′ (HR, 1.087;CI, 1.054–1.121; p < 0.001) were independent risk factors for CHA2DS2-VASc scores 2 or higher. CONCLUSIONS: Our findings suggest that increasing CHA2DS2-VASc scores are associatedwith impaired diastolic function that may represent high left atrial pressure favoringthrombogenic propensity.
Abstract
BACKGROUND: CHA2DS2-VASc is the most widely accepted scoring system for atrialfibrillation (AF) to assess stroke risk, although little has been revealed regarding theaccompanying cardiac functional/structural changes. This echocardiography study wasundertaken to understand the changes related to CHA2DS2-VASc scores. METHODS: A total of 4,795 nonvalvular AF patients were enrolled for the cohort, from which591 were excluded as they did not meet the inclusion criteria. Based on the CHA2DS2-VAScscores, the remaining 4,204 patients included in the study were divided into 4 groups: 0 to 1(n = 991); 2 to 3 (n = 1,642); 4 to 6 (n = 1,407); 7 to 9 (n = 164). RESULTS: Increase in the left ventricular mass index and prevalence of left ventricularhypertrophy (LVH) were observed with elevating CHA2DS2-VASc scores (p < 0.05 for all). Diastolic parameters such as left atrial volume index (LAVI) and the ratio of early diastolic mitralinflow velocity to early diastolic velocity of the mitral annulus (E/E′) also increased significantlyin the higher CHA2DS2-VASc score groups (p < 0.001 for all), although two-way ANOVA analysisshowed that such incremental diastolic impairment was independent of hypertension. LVH(hazard ratio [HR], 3.609; confidence interval [CI], 2.426–5.369; p < 0.001) and E/E′ (HR, 1.087;CI, 1.054–1.121; p < 0.001) were independent risk factors for CHA2DS2-VASc scores 2 or higher. CONCLUSIONS: Our findings suggest that increasing CHA2DS2-VASc scores are associatedwith impaired diastolic function that may represent high left atrial pressure favoringthrombogenic propensity.
참고문헌 (22)
- Camm AJ, "Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)", Europace, 12, pp.1360~1420 (2010)
- Akar JG, "Atrial fibrillation and thrombogenesis: innocent bystander or guilty accomplice?", JACC Clin Electrophysiol, 1, pp.218~219 (2015)
- Di Tullio MR, "Left atrial size and the risk of ischemic stroke in an ethnically mixed population", Stroke, 30, pp.2019~2024 (1999)
- Watson T, "Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited", Lancet, 373, pp.155~166 (2009)
- Gupta DK, "The prognostic significance of cardiac structure and function in atrial fibrillation: The ENGAGE AF-TIMI 48 Echocardiographic Substudy", J Am Soc Echocardiogr, 29, pp.537~544 (2016)
- Olesen JB, "Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study", BMJ, 342, pp.d124~ (2011)
- Nishimura RA, "2014 AHA", ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology, J Am Coll Cardiol, pp.2014, 63[DOI]
- Lang RM, "Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology", J Am Soc Echocardiogr, 18, pp.1440~1463 (2005)
- Cohn JN, "Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling", J Am Coll Cardiol, 35, pp.569~582 (2000)
- Jia X, "The CHA2DS2-VASc score: Not as simple as it seems", Int J Cardiol, 257, pp.92~96 (2018)
- Cuspidi C, "Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies", J Hum Hypertens, 26, pp.343~349 (2012)
- Eguchi K, "Association between diabetes mellitus and left ventricular hypertrophy in a multiethnic population", Am J Cardiol, 101, pp.1787~1791 (2008)
- Proietti M, "Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation", Am J Cardiol, 116, pp.877~882 (2015)
- Lim HS, "Thrombogenic risk in patients with atrial fibrillation: importance of comorbid conditions and intracardiac changes", JACC Clin Electrophysiol, 1, pp.210~217 (2015)
- Buono F, "Determinants of left ventricular hypertrophy in patients with recent diagnosis of essential hypertension", J Hypertens, 32, pp.166~173 (2014)
- Gerdts E, "Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network)", Int J Cardiol, 258, pp.257~261 (2018)
- study), "J Am Soc Echocardiogr", 1999, 1080~1087
- Ha JW, "Assessment of left atrial appendage filling pattern by using intravenous administration of microbubbles: comparison between mitral stenosis and mitral regurgitation", J Am Soc Echocardiogr, 14, pp.1100~1106 (2001)
- Shively BK, "Regional left atrial stasis during atrial fibrillation and flutter: determinants and relation to stroke", J Am Coll Cardiol, 27, pp.1722~1729 (1996)
- Schotten U, "Pathophysiological mechanisms of atrial fibrillation: a translational appraisal", Physiol Rev, 91, pp.265~325 (2011)
- 김효은, "Associates and Prognosis of Giant Left Atrium; Single Center Experience", Journal of Cardiovascular Imaging, 25(3), pp.84~90 (2017), 한국심초음파학회
- Okin PM, "Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension", JAMA, 296, pp.1242~1248 (2006)